(Q73132074)
Statements
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies (English)
Gratz S
Béhé M
Wörmann B
Gramatzki M
Riggert J
Griesinger F
Sharkey RM
Kolb HJ
Hiddemann W
Goldenberg DM